Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

______________________________________________________________________________

| 963 | *** Abrogată |

|_______|______________________________________________________________________|
______________________________________________________________________________

| 964 | *** Abrogată |

|_______|______________________________________________________________________|
#B

______________________________________________________________________________

| 965 |B05AA06| POLYGELINUM | |

|_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

B05AA06 POLYGELINUM SOL. PERF. 3.5%

HAEMACCEL 3.5% THERASELECT GMBH

________________________________________________________________________________

______________________________________________________________________________

| 966 |H01CB02| OCTREOTIDUM** | Protocol: H010C |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H01CB02 OCTREOTIDUM SOL. INJ. 0.1 mg/ml

SANDOSTATIN(R) 0.1 mg/ml NOVARTIS PHARMA GMBH
H01CB02 OCTREOTIDUM PULB. + SOLV. PT. SUSP. 10 mg

INJ. (I.M.) CU ELIB.

PRELUNG.

SANDOSTATIN LAR 10 mg 10 mg NOVARTIS PHARMA GMBH

H01CB02 OCTREOTIDUM PULB. + SOLV. PT. SUSP. 20 mg

INJ. (I.M.) CU ELIB.

PRELUNG.

SANDOSTATIN LAR 20 mg 20 mg NOVARTIS PHARMA GMBH

H01CB02 OCTREOTIDUM PULB. + SOLV. PT. SUSP. 30 mg

INJ. (I.M.) CU ELIB.

PRELUNG.

SANDOSTATIN LAR 30 mg 30 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________
______________________________________________________________________________

| 967 |J01CR05| PIPERACILLINUM + TAZOBACTAMUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CR05 PIPERACILLINUM + LIOF. PT. SOL. INJ.

TAZOBACTAMUM

TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH

TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH

________________________________________________________________________________

______________________________________________________________________________

| 968 |J01XA02| TEICOPLANINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01XA02 TEICOPLANINUM LIOF. + SOLV. PT. SOL. 400 mg

INJ.

TARGOCID(R) 400 mg 400 mg AVENTIS PHARMA LTD.

________________________________________________________________________________
______________________________________________________________________________

| 969 |J01XX08| LINEZOLIDUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALA 100 mg/5 ml

ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEIG
J01XX08 LINEZOLIDUM SOL. PERF. 2 mg/ml

ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEIG

J01XX08 LINEZOLIDUM COMPR. FILM. 600 mg

ZYVOXID(R) 600 mg PFIZER EUROPE MA EEIG

________________________________________________________________________________
______________________________________________________________________________

| 970 |J02AB02| KETOCONAZOLUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Candidoza genitală simptomatică recurentă după